Skip to main content
Clinical Trials/ACTRN12610001029088
ACTRN12610001029088
Not yet recruiting
Phase 2

A feasibility study for a randomized controlled trial of Gastrografin in the management of malignant bowel obstruction

Ian Bissett0 sites20 target enrollmentNovember 23, 2010

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Malignant bowel obstruction
Sponsor
Ian Bissett
Enrollment
20
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 23, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ian Bissett

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria
  • \-Age \>18 years
  • \-Satisfy criteria for a MBO
  • \-No indication for immediate surgery
  • \-Able to understand the risks/benefits of the study
  • \-Able to give informed written consent
  • \-Any further treatment (surgery, chemotherapy,
  • radiotherapy, hormone therapy, biological/targeted
  • therapies) is deemed by relevant practitioners unlikely
  • to change the acute management of the bowel

Exclusion Criteria

  • Exclusion Criteria
  • \-Known allergic reaction to study medication or
  • \-Grossly distended stomach on radiologic exam
  • \-Venting or feeding gastrostomy or jejunostomy
  • \-Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials